• Jun 6, 2025Schott Pharma invests €100M in sterile cartridge production | US Pharmacopeia opens lab for pharma manufacturing innovation
    Jun 5, 2025Agenus makes quick exit from CDMO business | TriLink, Quantoom ink deal on mRNA capping technology
    Jun 4, 2025Fujifilm life sciences companies get rebranding | Kivu, Sterling team for manufacturing of ADC candidate
    Jun 3, 2025Syngene’s first US manufacturing facility | Bora Pharmaceuticals to add sterile fill-finish line
    May 31, 2025Industry pushes back on pharma tariff threat | SK bioscience expands vaccine manufacturing site to support Sanofi
    May 30, 2025BrainStorm taps Minaris for Phase 3b ALS cell therapy manufacturing | Wacker, Expression team on lentiviral vector production
    May 29, 2025Novartis to launch cell culture system in Austria | FDA rejects drug candidate, cites missing CMC data
    May 28, 2025Sanofi, VNVC open Vietnam vaccine plant | Siegfried boosts eye drug production in Spain
    May 24, 2025Samsung Biologics to become pure-play CDMO | Bora Biologics expands San Diego facility
    May 23, 2025Bachem scales up peptide, oligonucleotide production | Northway inks manufacturing pact with Kaida BioPharma
    May 22, 2025Thermo Fisher to be Mirai Bio’s preferred CDMO | CellProthera selects CELLforCURE for Phase 3 GMP manufacturing
    May 21, 2025Cellino nabs FDA AMT nod for iPSC manufacturing | GC Biopharma and Körber fast‑track MES rollout
    May 20, 2025Biosimilar approvals seen as boon for CMOs | Trump launches AI drug manufacturing push
    May 17, 2025World’s first mRNA-based personalized CRISPR therapy | Thermo Fisher provides manufacturing for Phase 3 program
    May 16, 2025Roche warns Trump’s pricing order threatens $50B US investment | Sanofi commits $20B to US R&D, manufacturing
    May 15, 2025WuXi Biologics sells German site to Terumo for $168M | Recipharm, PLG team up on drug development and approvals
    May 14, 2025Bayer says tariffs won’t impact manufacturing footprint | Piramal Pharma to expand two US sites with $90M investment
    May 13, 2025Genentech plans $700M NC plant | Lilly invests $250M in Purdue partnership
    May 10, 2025Takeda plans $30B US investment over 5 years | Lonza reaffirms 2025 outlook after strong Q1
    May 9, 2025Gilead invests $11B to expand US manufacturing | Ratio Therapeutics plans new radiopharma site in Utah
    May 8, 2025AGC teams with Novelty Nobility on antibody drug | Aptar CSP opens cGMP packaging site
    May 7, 2025US exercises $144M option for freeze-dried mpox vaccine | Xellia to close Copenhagen site over 10 years
    May 6, 2025Samsung Biologics inks $518M deal with unnamed US firm | Matica Bio, NCTM team up on CGT development
    May 3, 2025Lilly CEO urges tax reform over tariffs | BMS shuts Illinois viral vector site
    May 2, 2025Biogen says 2025 outlook unaffected by potential tariffs | EMA approves new API site for Pegasys
    Latest Edition